BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2006
View Archived Issues
Regeneron reports progress across key programs in first quarter
Read More
CPG-10101 improves responses in relapsed hepatitis C treatment responders
Read More
In vitro data show activity of AR-709 against multidrug resistant S. pneumoniae
Read More
Phase I study of TNX-650 begins dosing
Read More
AVANT study to resume enrollment
Read More
QR-435 to be studied for ocular herpes in animals
Read More
Immtech enters expanded funding agreements for pafuramidine maleate
Read More
Updated survival data from phase I study of DCVax-Brain in GBM patients
Read More
Screening begins in phase III trial of NRP-104 for adult ADHD
Read More
Two new phase II studies for ZK-EPO in breast and ovarian cancers
Read More
FDA clears ALK-Abello to begin phase I study of ragweed allergy vaccine tablet
Read More
Avanir to acquire Alamo Pharmaceuticals
Read More
Novartis involved in new public-private partnership for malaria
Read More
Enrollment open in phase II study of TroVax for prostate cancer
Read More
Teriparatide studied in new trial for osteogenesis imperfecta
Read More
SB-462795 increases bone strength in male monkeys
Read More
Once-daily carvedilol effective in patients with hypertension
Read More
Randomized trials reveal efficacy of valsartan and valsartan/amlodipine in hypertension
Read More
Herceptin approved in Europe for early use in HER2-positive breast cancer
Read More
FDA approval for Ionsys transdermal analgesic system
Read More
Equasym for ADHD completes European mutual recognition procedure
Read More
Novel treatment strategies for cancer covered in recent patents
Read More
Chemokine CXCR4 antagonists reported by Merck & Co.
Read More
Recent Kotobuki patent describes new agents for hyperphosphatemia
Read More
Novel motilin receptor agonist shows in vivo efficacy as prokinetic agent
Read More
MD-1100's active metabolite characterized in vitro and in vivo by Microbia
Read More
Selective adenosine A2A receptors with potential in CNS disorders developed by Schering-Plough
Read More
Curcumin derivative shows potential for the treatment of colon cancer by blocking EGFR signaling
Read More
